MINOGUE MICHAEL R — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

MINOGUE MICHAEL R has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $500K.

Profile

Michael R. Minogue is a corporate executive known for his role as a director at Insulet Corporation, a company specializing in insulin delivery systems for diabetes management. He has significant experience in the medical device industry and has contributed to the advancement of diabetes care technologies.

Board memberships

• Insulet Corporation

Awards & honors

• Director at Insulet Corporation
• Contributed to the development of the Omnipod system

Recent Transactions

Companies — Last 90 Days

• INSULET CORP (PODD) — 1 filings, last 2026-05-21

Frequently Asked Questions

Who is MINOGUE MICHAEL R?

Michael R. Minogue is a corporate executive known for his role as a director at Insulet Corporation, a company specializing in insulin delivery systems for diabetes management. He has significant experience in the medical device industry and has contributed to the advancement of diabetes care technologies.…

How many SEC Form 4 filings has MINOGUE MICHAEL R submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has MINOGUE MICHAEL R been buying or selling stock?

Recorded transactions: 1 open-market purchases ($500K) and 0 open-market sales () across all tracked filings.

Where can I see all of MINOGUE MICHAEL R's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week